Clinical Trials Browser

Withdrawn × spartalizumab × Thoracic × Clear all

NCT03945227 2020-10-19

Clinical Trial for Evaluating Efficacy and Safety of PDR001 in Concurrent Plus Consolidation Versus Consolidation Only in Addition to Standard Chemoradiotherapy in Unresectable Stage III NSCLC Patients (PASTURE)

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT03982134 2019-10-04

PDR001 + Panobinostat for Melanoma and NSCLC

Phase 1 Withdrawn

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT02466568 2019-09-09

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis